INTERNATIONAL PATENT: CHONG KUN DANG PHARMACEUTICAL CORP. FILES APPLICATION FOR "GLP-1 RECEPTOR AGONIST AND USES THEREOF"

GENEVA, Dec. 30 -- CHONG KUN DANG PHARMACEUTICAL CORP. (8, Chungjeong-ro,Seodaemun-gu,Seoul 03742) filed a patent application (PCT/KR2025/008533) for "GLP-1 RECEPTOR AGONIST, AND USES THEREOF" on Jun 19, 2025. With publication no. WO/2025/264023, the details related to the patent application was published on Dec 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MIN, Jaeki (315-20, Dongbaekjukjeon-daero, Giheung-gu,Yongin-si,Gyeonggi-do 16995), LEE, Jaekwang (315-20, Dongbaekjukjeon-daero, Giheung-gu,Yongin-si,Gyeonggi-do 16995), IN, Jinkyung (315-20, Dongbaekjukjeon-daero, Giheung-gu,Yongi...